Want to see JP:6368 full AI Analyst Report?
6368 Stock Chart & Stats
¥13385.00
-¥140.00(-0.92%)
At close: 4:00 PM EDT
¥13385.00
-¥140.00(-0.92%)
Day’s Range― - ―
52-Week Range¥10,980.00 - ¥20,145.00
Previous CloseN/A
Volume368.30K
Average Volume (3M)281.63K
Market Cap
¥569.71B
Enterprise Value¥759.04K
Total Cash (Recent Filing)¥27.84B
Total Debt (Recent Filing)¥37.36B
Price to Earnings (P/E)20.1
Beta1.84
Next Earnings
Nov 02, 2026EPS Estimate
162.74Next Dividend Ex-DateN/A
Dividend Yield1.59%
Share Statistics
EPS (TTM)613.21
Shares Outstanding46,359,700
10 Day Avg. Volume182,260
30 Day Avg. Volume281,633
Financial Highlights & Ratios
PEG Ratio1.25
Price to Book (P/B)4.38
Price to Sales (P/S)3.52
P/FCF Ratio21.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)671.26
Revenue Forecast (FY)¥203.90B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained revenue expansion indicates continuing demand for Organo’s water-treatment systems and services. Although the latest growth rate moderated, the multi-year progression supports an established market position and provides a durable base for future earnings and investment.
Material Margin ExpansionThe substantial improvement in gross and net margins strengthens earnings quality and suggests better pricing, product mix, and/or cost control. Higher profitability can support reinvestment, improve resilience during slower growth, and enhance the company’s ability to generate shareholder returns.
Strong Current Cash GenerationStrong recent operating and free cash flow indicates that reported earnings are converting effectively into cash. This supports funding for operations and growth with less reliance on external capital, while the high free-cash-flow conversion provides a useful foundation for financial flexibility.
Bears Say
Recent Debt IncreaseThe recent rise in borrowing adds financial risk even though leverage remains moderate. Organo will need continued earnings and cash-flow strength to keep debt manageable, preserve balance-sheet flexibility, and avoid allowing higher financing obligations to constrain future capital allocation.
Historically Volatile Cash FlowPast periods of negative operating and free cash flow show that cash conversion has not been consistently strong across the full cycle. This volatility may reflect execution or working-capital timing and makes future funding capacity less predictable than the latest results alone suggest.
Moderating Revenue GrowthSlower recent top-line growth may indicate a maturing growth cycle or tougher comparisons, reducing the pace at which Organo can expand its earnings base. Sustaining margin gains becomes more important if revenue growth remains below its earlier trajectory.
6368 FAQ
What was Organo Corp.’s price range in the past 12 months?
Organo Corp. lowest stock price was ¥10980.00 and its highest was ¥20145.00 in the past 12 months.
What is Organo Corp.’s market cap?
Organo Corp.’s market cap is ¥569.71B.
When is Organo Corp.’s upcoming earnings report date?
Organo Corp.’s upcoming earnings report date is Nov 02, 2026 which is in 53 days.
How were Organo Corp.’s earnings last quarter?
Organo Corp. released its earnings results on Aug 03, 2026. The company reported ¥74.73 earnings per share for the quarter, missing the consensus estimate of ¥134.22 by -¥59.49.
Is Organo Corp. overvalued?
According to Wall Street analysts Organo Corp.’s price is currently Overvalued.
Does Organo Corp. pay dividends?
Organo Corp. pays a Semiannually dividend of ¥110 which represents an annual dividend yield of 1.59%. See more information on Organo Corp. dividends here
What is Organo Corp.’s EPS estimate?
Organo Corp.’s EPS estimate is 162.74.
How many shares outstanding does Organo Corp. have?
Organo Corp. has 46,359,700 shares outstanding.
What happened to Organo Corp.’s price movement after its last earnings report?
Organo Corp. reported an EPS of ¥74.73 in its last earnings report, missing expectations of ¥134.22. Following the earnings report the stock price went down -0.238%.
Which hedge fund is a major shareholder of Organo Corp.?
Currently, no hedge funds are holding shares in JP:6368
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Organo Corp.
Organo Corporation, a Tokyo-headquartered enterprise established in 1941 (and known as Japan Organo Co., Ltd. until its name change in 1966), is a global specialist in water treatment engineering. The company's business activities are structured into two main divisions: the Water Treatment Engineering Business Unit and the Performance Products Business Unit. It offers a comprehensive portfolio of water purification solutions, encompassing various pure water systems such as reverse osmosis (RO), regenerative (automatic and manual), electric regeneration, desktop, cabinet, electrode ionization high-purity, cartridge, and two-stage RO systems. Additionally, Organo supplies ultrapure water systems, available in desktop and cabinet models, alongside final polishing units. The company's equipment range extends to include alkaline electrolyzed water production machinery, homogenizers, electro conductivity and resistivity meters, and ion exchange filters. Beyond physical systems, Organo Corporation provides specialized chemicals for water, wastewater, and RO treatment. Its extensive selection of industrial filters covers micro, sanitary, polypropylene, and plastic housings, as well as micro, RO wound, PF cartridge, capsule, and PF carbon filters. Commercial water purifiers are also part of its product offering. Organo's expertise is applied across numerous industries: delivering ultrapure and multi-functional water production, wastewater treatment, valuable resource recovery, and organic solvent refining systems for the electronics sector; constructing water supply and sewage treatment facilities; supplying purified water, UF water, and water for injection production and supply systems, coupled with consulting services, for the pharmaceutical industry; providing critical solutions for power generation, including condensate filters, demineralizers, reactor and fuel pool cleanup, makeup water, and waste water treatment systems; and implementing sugar refining systems and associated equipment.
Technical Analysis
Kurita Water Industries
―
METAWATER Co
―
Takuma Co
―
Mitsubishi Kakoki Kaisha,Ltd.
―
Hitachi Zosen Corporation
―
